Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exjade vs Desferal for ferritin reduction in pediatric patients with major thalassemia
IRCT2015042114333N32Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of deferasirox and deferoxamine in beta thalassemia major (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Change in serum ferritin level. Started May 2015; status: completed.
02
Drugs
deferasiroxdeferoxamine
03
Conditions
beta thalassemia major
Beyond the preview
Go deeper on IRCT2015042114333N32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015042114333N32.